Search results
Martin B. Leon, MD is a professor and chief innovation officer at Columbia University Irving Medical Center, and a leader in interventional cardiovascular medicine. He has participated in over 50 clinical trials, founded the Cardiovascular Research Foundation and TCT conference, and performed over 10,000 interventional procedures.
Martin B. Leon, MD, is a Professor of Medicine at Columbia University Irving Medical Center in New York, NY, as well as Chief Innovation Officer and the Director of the Cardiovascular Data Science Center for the Division of Cardiology.
Mar 15, 2019 · Martin B. Leon, MD, a pioneer in the development of minimally invasive therapies for individuals with heart disease, will be honored with the 2019 Lifetime Achievement Award by the American College of Cardiology (ACC) at its 68th annual scientific sessions in New Orleans.
- Tell Us About Your background?
- Why Did You Choose Cardiology?
- How Did You Get Involved in Interventional Cardiology?
- How Did Your Research Focus Change in The Early Years of The Millennium?
- What Is on The Horizon in Interventional Cardiology?
My parents were immigrants to the USA and did not have a background in medicine and my reasons for choosing medicine as a profession were intensely personal. During my childhood, I was exposed to family illness, and I witnessed first-hand the dramatic effects on my parents and siblings. I made a bold statement at the age of six that I would try to ...
Again, for personal reasons initially relating to the death of my grandmother, who had a heart attack and literally died in my arms. That emotional motivation led to a fascination with heart disease, from diagnosis to therapy. At that time, the high mortality and morbidity associated with heart disease was not adequately addressed with meaningful d...
During my years at the NIH as a Senior Investigator and later as the Director of the Catheterization Laboratory, I was exposed to a broad range of clinical and research experiences including animal investigation, design, and execution of clinical trials and the early days of coronary angioplasty. We were the third group in the USA to treat coronary...
During the 1990s, I was the research director of an influential interventional cardiology group in Washington DC, and we helped to develop many of the newer angioplasty techniques from the standpoint of clinical practice and clinical research. I was convinced that evidence-based medicine applied in rigorous clinical trials would help to establish o...
The field of structural heart disease is indeed very expansive, incorporating all transcatheter or catheter-based techniques to treat non-vascular structures in the heart. Undoubtedly, we will be focusing on mitral and tricuspid regurgitation in the next many years, which likely will require more of a ‘toolbox’ approach requiring many different dev...
- Judith Ozkan
- 2021
Oct 14, 2020 · Leon is a distinguished pioneer in interventional cardiology and the founder and director of Transcatheter Cardiovascular Therapeutics (TCT), a leading scientific symposium dedicated to interventional cardiovascular medicine.
May 16, 2024 · A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national Principal Investigator for multiple landmark clinical trials, including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and, most recently, the PARTNER trial. Declaration of interest. Information not available at the time of editing. Latest contributions.
People also ask
Who is Martin Leon?
Who is Dr Martin Leon?
What does Dr Leon do?
Who is Leon Leon?
Jan 6, 2017 · For Professor Martin Leon, MD, as a pioneer of less-invasive catheter-based techniques, real-life family experiences have been an important element, even from his earliest years.
